Adib Essali

1.4k total citations
28 papers, 912 citations indexed

About

Adib Essali is a scholar working on Psychiatry and Mental health, Philosophy and Pharmacology. According to data from OpenAlex, Adib Essali has authored 28 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 5 papers in Philosophy and 4 papers in Pharmacology. Recurrent topics in Adib Essali's work include Schizophrenia research and treatment (18 papers), Mental Health and Psychiatry (5 papers) and Bipolar Disorder and Treatment (5 papers). Adib Essali is often cited by papers focused on Schizophrenia research and treatment (18 papers), Mental Health and Psychiatry (5 papers) and Bipolar Disorder and Treatment (5 papers). Adib Essali collaborates with scholars based in Syria, New Zealand and United Kingdom. Adib Essali's co-authors include Kristian Wahlbeck, Maxim V. Cheine, Clive E Adams, John Rathbone, Chunbo Li, Ghassan Ahmed Alı, Suaad Moussa, Hanan E. Badr, Marwan M. Al‐Sharbati and Karla Soares‐Weiser and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Cochrane Database of Systematic Reviews.

In The Last Decade

Adib Essali

28 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adib Essali Syria 11 574 213 168 132 116 28 912
Siow‐Ann Chong Singapore 23 795 1.4× 201 0.9× 164 1.0× 82 0.6× 97 0.8× 43 1.1k
A. Elif Anıl Yağcıoğlu Türkiye 16 647 1.1× 186 0.9× 118 0.7× 166 1.3× 104 0.9× 59 976
Bin Fang China 7 591 1.0× 146 0.7× 164 1.0× 39 0.3× 110 0.9× 12 835
Stuart Kushner United States 14 1.0k 1.8× 250 1.2× 96 0.6× 117 0.9× 42 0.4× 19 1.2k
Haiyan Xu United States 15 629 1.1× 136 0.6× 153 0.9× 62 0.5× 117 1.0× 30 936
Thomas J. Arndt United States 8 760 1.3× 147 0.7× 117 0.7× 57 0.4× 131 1.1× 8 1.1k
Maosheng Fang China 15 523 0.9× 146 0.7× 68 0.4× 61 0.5× 132 1.1× 29 974
Atheeshaan Arumuham United Kingdom 8 517 0.9× 110 0.5× 74 0.4× 104 0.8× 117 1.0× 19 907
Luke Vano United Kingdom 5 545 0.9× 96 0.5× 84 0.5× 62 0.5× 109 0.9× 10 823
Joseph McEvoy United States 7 838 1.5× 231 1.1× 274 1.6× 53 0.4× 55 0.5× 13 1.0k

Countries citing papers authored by Adib Essali

Since Specialization
Citations

This map shows the geographic impact of Adib Essali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adib Essali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adib Essali more than expected).

Fields of papers citing papers by Adib Essali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adib Essali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adib Essali. The network helps show where Adib Essali may publish in the future.

Co-authorship network of co-authors of Adib Essali

This figure shows the co-authorship network connecting the top 25 collaborators of Adib Essali. A scholar is included among the top collaborators of Adib Essali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adib Essali. Adib Essali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saadi, Tareq Al, et al.. (2021). Coenzyme Q10 for heart failure. Cochrane Database of Systematic Reviews. 2021(2). CD008684–CD008684. 39 indexed citations
2.
Essali, Adib, et al.. (2019). Haloperidol discontinuation for people with schizophrenia. Cochrane Database of Systematic Reviews. 2019(4). CD011408–CD011408. 9 indexed citations
3.
Essali, Adib, Karla Soares‐Weiser, Hanna Bergman, & Clive E Adams. (2018). Calcium channel blockers for antipsychotic-induced tardive dyskinesia. Cochrane Database of Systematic Reviews. 2018(3). CD000206–CD000206. 4 indexed citations
4.
Turk, Tarek, et al.. (2017). Fluphenazine (dose) for people with schizophrenia. Cochrane Database of Systematic Reviews. 2 indexed citations
5.
Hanafi, Ibrahem, et al.. (2017). Haloperidol (route of administration) for people with schizophrenia. Cochrane Database of Systematic Reviews. 10 indexed citations
6.
Turk, Tarek, et al.. (2017). Risperidone (oral forms) for people with schizophrenia. Cochrane Database of Systematic Reviews. 3 indexed citations
7.
Abbas, Fatima, et al.. (2017). Fluphenazine decanoate (timing of administration) for people with schizophrenia. Cochrane Database of Systematic Reviews. 3 indexed citations
8.
Hanafi, Ibrahem, et al.. (2016). Cariprazine versus placebo for schizophrenia. Cochrane Database of Systematic Reviews. 1 indexed citations
9.
Essali, Adib, et al.. (2013). Preventive Interventions for Postnatal Psychosis. Schizophrenia Bulletin. 39(4). 748–750. 1 indexed citations
10.
Essali, Adib, et al.. (2013). Preventive interventions for postnatal psychosis. Cochrane Database of Systematic Reviews. 2013(6). CD009991–CD009991. 4 indexed citations
11.
Essali, Adib, et al.. (2012). Specialist interventions for homeless people with severe mental illness. Cochrane Database of Systematic Reviews. 1 indexed citations
12.
Qintar, Mohammed, et al.. (2012). Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy. Cochrane Database of Systematic Reviews. 2021(4). CD008523–CD008523. 17 indexed citations
13.
Essali, Adib & Ghassan Ahmed Alı. (2012). Antipsychotic drug treatment for elderly people with late-onset schizophrenia. Cochrane Database of Systematic Reviews. 2013(2). CD004162–CD004162. 23 indexed citations
14.
Essali, Adib, et al.. (2011). Calcium channel blockers for neuroleptic-induced tardive dyskinesia. Cochrane Database of Systematic Reviews. CD000206–CD000206. 31 indexed citations
15.
Essali, Adib, et al.. (2009). Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database of Systematic Reviews. 2010(1). CD000059–CD000059. 186 indexed citations
16.
Al‐Sharbati, Marwan M., et al.. (2008). Use of M-CHAT for a multinational screening of young children with autism in the Arab countries. International Review of Psychiatry. 20(3). 281–289. 108 indexed citations
17.
Almerie, Muhammad Qutayba, et al.. (2007). Cessation of Medication for People With Schizophrenia Already Stable on Chlorpromazine. Schizophrenia Bulletin. 34(1). 13–14. 18 indexed citations
18.
Almerie, Muhammad Qutayba, et al.. (2007). Cessation of medication for people with schizophrenia already stable on chlorpromazine. Cochrane Database of Systematic Reviews. 2013(12). CD006329–CD006329. 14 indexed citations
19.
Wahlbeck, Kristian, Maxim V. Cheine, & Adib Essali. (1999). Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database of Systematic Reviews. CD000059–CD000059. 85 indexed citations
20.
Wahlbeck, Kristian, Maxim V. Cheine, Adib Essali, & Clive E Adams. (1999). Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials. American Journal of Psychiatry. 156(7). 990–999. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siow‐Ann Chong Breakdown of academic impact, for papers by A. Elif Anıl Yağcıoğlu Breakdown of academic impact, for papers by Bin Fang Breakdown of academic impact, for papers by Stuart Kushner Breakdown of academic impact, for papers by Haiyan Xu Breakdown of academic impact, for papers by Thomas J. Arndt Breakdown of academic impact, for papers by Maosheng Fang Breakdown of academic impact, for papers by Atheeshaan Arumuham Breakdown of academic impact, for papers by Luke Vano Breakdown of academic impact, for papers by Joseph McEvoy
Rankless by CCL
2026